Your browser doesn't support javascript.
loading
Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss.
Andrade-Vieira, Rafaela; Goguen, Donna; Bentley, Heidi A; Bowen, Chris V; Marignani, Paola A.
Afiliação
  • Andrade-Vieira R; Department of Biochemistry and Molecular Biology, Dalhousie University, Faculty of Medicine, Halifax, Nova Scotia Canada.
  • Goguen D; Department of Biochemistry and Molecular Biology, Dalhousie University, Faculty of Medicine, Halifax, Nova Scotia Canada.
  • Bentley HA; Department of Biochemistry and Molecular Biology, Dalhousie University, Faculty of Medicine, Halifax, Nova Scotia Canada.
  • Bowen CV; Department of Radiology, Halifax, Nova Scotia Canada.
  • Marignani PA; Department of Biochemistry and Molecular Biology, Dalhousie University, Faculty of Medicine, Halifax, Nova Scotia Canada.
Oncotarget ; 5(24): 12738-52, 2014 Dec 30.
Article em En | MEDLINE | ID: mdl-25436981

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Serina-Treonina Quinases / Serina-Treonina Quinases TOR / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Serina-Treonina Quinases / Serina-Treonina Quinases TOR / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article